Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin

A Jain, P Kesharwani, NK Garg, A Jain, SA Jain… - Colloids and Surfaces B …, 2015 - Elsevier
The present investigation reports the preparation, optimization, and characterization of
surface engineered solid lipid nanoparticles (SLNs) encapsulated with doxorubicin (DOX) …
被引用次数：155 相关文章
[PDF] academia.edu

[PDF][PDF] Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin

A Jain, P Kesharwani, NK Garg, A Jain… - Colloids and Surfaces …, 2015 - academia.edu
abstract The present investigation reports the preparation, optimization, and characterization
of surface engineered solid lipid nanoparticles (SLNs) encapsulated with doxorubicin …

Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin

A Jain, P Kesharwani, NK Garg… - … and surfaces. B …, 2015 - pubmed.ncbi.nlm.nih.gov
The present investigation reports the preparation, optimization, and characterization of
surface engineered solid lipid nanoparticles (SLNs) encapsulated with doxorubicin (DOX) …

Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin.

A Jain, P Kesharwani, NK Garg, SA Jain… - Colloids and surfaces …, 2015 - europepmc.org
The present investigation reports the preparation, optimization, and characterization of
surface engineered solid lipid nanoparticles (SLNs) encapsulated with doxorubicin (DOX) …

Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin

A Jain, P Kesharwani, NK Garg, A Jain, SA Jain… - Colloids and Surfaces B …, 2015 - infona.pl
The present investigation reports the preparation, optimization, and characterization of
surface engineered solid lipid nanoparticles (SLNs) encapsulated with doxorubicin (DOX) …

[引用][C] Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin

A Jain, P Kesharwani, NK Garg, A Jain, SA Jain… - 2015